Preprint
Article

This version is not peer-reviewed.

Antioxidant, Photoprotective, and Antimicrobial Potential of Oil Extract of Usnea barbata L. F.H.Wigg from Călimani Mountains, Romania

A peer-reviewed version of this preprint was published in:
Molecules 2026, 31(8), 1324. https://doi.org/10.3390/molecules31081324

Submitted:

20 March 2026

Posted:

24 March 2026

You are already at the latest version

Abstract
In order to enhance the value and stability of vegetable oils, they may be enriched with essential oils and plant extracts with strong antioxidant activity, yielding innovative formulations with potential applications in skincare. The present research aims to investigate the bioactive properties of an Usnea barbata extract in Jojoba oil (JO) enriched with 5% Peppermint oil (PEO), and 10% vitamin E (PJO). The oil extract (UBPJO) was obtained through cold maceration. The UBPJO antioxidant activity was investigated using 2 methods (DPPH and ABTS). The sunscreen capacity of UBPJO was evaluated by measuring their sun protection factor (SPF) values. The antimicrobial potential was investigated against S. aureus, E. coli, and C. albicans. The antioxidant activity of UBPJO was 1.5 times higher than PJO. Consequently, the sunscreen efficacy (assessed by SPF measurements) indicated satisfactory UVB protection abilities against S. aureus (UBPJO vs. PJO: 32.41 vs. 30.58). UBPJO exhibited significantly greater inhibitory effects compared to PJO against S. aureus (MIC = 18.75 ± 6.25 vs. 37.50 ± 0.00, p < 0.05). and C. albicans (9.62 ± 2,87 vs. 37.5 ± 12.5, p < 0.05). The bioactive properties investigated in the present study support the inclusion of UBPJO in various skin protective formulations with antiaging, antibacterial, and antifungal effects.
Keywords: 
;  ;  ;  ;  ;  ;  

1. Introduction

Achieving and maintaining healthy skin involves a comprehensive approach that incorporates daily protection, targeted skincare routines, and mindful lifestyle choices [1]. One of the most significant contributors to visible skin aging is UV exposure, which accounts for 80–90% of the signs of aging [2,3,4].
Exposure to ultraviolet (UV) radiation is a major stress factor for the skin, directly affecting epidermal cellular structure and function and often causing various skin cancers. Ultraviolet B (UVB) radiation, with wavelengths between 280 and 320 nm, triggers an acute inflammatory response of the skin, mainly mediated by proinflammatory substances derived from arachidonic acid (prostaglandins and leukotrienes)[5]. It is mainly responsible for erythema, skin alterations, and even carcinogenesis [6,7,8,9]. On the other hand, UVA radiation, spanning 320-400 nm, penetrates more deeply, leading to the development of skin photoaging, characterized by reduced elasticity, skin tone loss, collagen breakdown, and wrinkles [10,11].
According to literature data, chronic exposure to UV radiation results in oxidative stress via ROS generation, DNA damage, hyperpigmentation, premature photoaging, and increases the long-term risk of melanoma and non-melanoma skin cancers [12,13]. Therefore, making daily sun protection a non-negotiable part of a skincare regimen is essential. This can include using a broad-spectrum sunscreen with at least SPF 30, as well as incorporating antioxidants, moisturizers, and antimicrobials, which can enhance overall skin health and resilience against aging [14,15]. Most commercial formulations contain chemical or mineral filters that can cause irritation, sensitization, or environmental harm [16,17,18,19,20,21,22]. Therefore, modern consumers are increasingly aware of the potential health risks posed by synthetic chemicals in personal care products [23,24], driving a significant shift toward natural, eco-friendly cosmetic formulations. This trend has spurred extensive scientific research into plant-derived compounds that can serve as functional ingredients in cosmetics — offering not only aesthetic benefits but also health-promoting effects, including sunburn protection and antioxidant and antimicrobial properties [25,26,27,28,29].
Various cosmetic ingredients can be identified using the International Nomenclature of Cosmetic Ingredients (INCI), which provides a standardized system to ensure clarity and consistency in the cosmetics industry. It contains over 30,000 INCI names, chemical structures, synonyms, and regulatory references. The International Cosmetic Ingredient Dictionary and Handbook, where these names are listed, is also available electronically as wINCI, making it easily accessible for those in the field. This system enhances transparency and fosters trust among consumers and manufacturers alike, and is available online at https://www.personalcarecouncil.org/resources/inci/. The European Commission official Database (CosIng, available online at https://ec.europa.eu/growth/tools-databases/cosing/) includes over 15,000 ingredients and provides details on the INCI name, CAS number, ingredient functions, and possible restrictions on use under Regulation (EC) No 1223/2009. As an initiative of the European cosmetics industry, COSMILE Europe provides transparent, easy-to-understand information for consumers about the safety and role of each ingredient, available online at https://cosmileeurope.eu/. It contains approximately 30,000 cosmetic ingredients. A plant-derived product with multiple benefits for skincare, included in the above-mentioned databases, is a lichen extract (Usnea barbata extract) available online at https://cosmileeurope.eu/inci/detail/16750/usnea-barbata-extract/. Over six years (2016 – 2022), as part of a doctoral and postdoctoral project, our team investigated the composition and bioactivities of U. barbata harvested from an unpolluted zone in the Calimani Mountains. U. barbata extracts were obtained in various solvents (ethanol, methanol, ethyl-acetate, acetone, and Canola oil) through different methods (maceration and Soxhlet extraction). Usnic acid and other phenolic secondary metabolites were identified and quantified through UHPLC (caffeic acid, p-coumaric acid, ellagic acid, chlorogenic acid, cinnamic acid, and gallic acid) [30,31,32,33,34,35]. We also isolated usnic acid from the dry U. barbata extract in ethyl acetate by semi-preparative chromatography [36], and validated a UHPLC method for the determination of usnic acid content in U. barbata extract in Canola oil [35]. Moreover, the most active extracts were incorporated in mucoadhesive oral films with potential applications in oral cancer [37,38,39,40].
Based on our previously published results, U. barbata harvested from the same unpolluted zone of the Calimani Mountains in the same period was extracted in a mixed oil solvent, Jojoba oil (JO) enriched with 5% Peppermint essential oil (PEO) and 10% vitamin E. We recently identified the bioactive constituents (using the GC-MS method), determined the total phenolic content (including usnic acid and other phenolic acids), and investigated the physicochemical properties of this complex oil extract, with potential applications in the cosmetic field [41]. Our published results indicated that the combination of all four ingredients (UBPJO) creates a multifunctional cosmetic system in which each ingredient contributes complementary properties (Table 1) [41].
The addition of U. barbata extract to the already antioxidant-rich base of Jojoba oil, Peppermint oil, and Vitamin E significantly increased the total phenolic content. This suggests a true additive-to-synergistic enhancement of antioxidant capacity, because:
o  
Vitamin E (tocopherol) contributes lipid-soluble radical-scavenging activity
o  
Peppermint oil contributes terpenes with antioxidant properties
o  
Jojoba oil provides a stable, oxidation-resistant liquid wax matrix
o  
U. barbata is rich in unique lichen secondary metabolites with phenolic structure (e.g., usnic acid, depsides, depsidones) that substantially boost the total phenolic content [30,33,59,60,61,62].
AFM and FTIR analyses confirmed the physicochemical compatibility of the combined ingredients [41]:
o  
AFM revealed surface roughness differences between PJO and UBPJO, indicating that U. barbata extract integrates into the oil matrix and modifies its microstructure;
o  
FTIR confirmed the chemical integrity of the combined formulation, showing no destructive interactions between components.
Therefore, the combination has a higher oxidative stability [41], suggesting that U. barbata phenolics synergize with Vitamin E to quench free radicals more effectively, Jojoba oil’s inherent stability (as a liquid wax ester rather than a triglyceride) provides a protective matrix that slows oxidative chain reactions [63,64], and Peppermint oil’s volatile antioxidants contribute an additional layer of protection [44,65].
This complex formulation also showed improvements in rheological properties [41]. These aspects are relevant because they affect the bioavailability of active compounds at the skin surface — a more spreadable formulation ensures better contact time and penetration of the antioxidant, antimicrobial, and UV-protective compounds.
All previous findings support the conclusion that the four ingredients work synergistically rather than merely additively, making the combined formulation a promising candidate for natural, multifunctional skincare products.
As an innovative approach in developing natural skin care products, UBPJO-based formulations are expected to combine emollient, antioxidant, and antimicrobial effects with slightly enhanced UV protection. Thus, the present study aims to investigate the antioxidant activity, sunscreen properties, and antimicrobial potential of U. barbata extract in JO enriched with 5% Peppermint oil and 10% vitamin E.

2. Results

2.1. Antioxidant Activity

To accurately evaluate the antioxidant activity of PJO and UBPJO, the samples were diluted in methanol (1:1, 1:5, 1:10, and 1:25) and compared with a solvent-based standard.

2.1.1. DPPH Method

The in vitro radical-scavenging capacity of PJO and UBPJO was assessed using the DPPH method, with both kinetic and endpoint measurements (Figure 1).
PJO has an OD trajectory similar to that of UBPJO (Figure 1A and 1 B). However, the ΔOD values are lower than those of UBPJO (Figure 1C and D). The highest PJO dilution (1:25) has the second-most intense antioxidant effect after the stock solution (ΔOD = 5.87% vs. 11.87%, Figure 1C).
Our results show that the standard OD dynamics was 4,74%. For the UBPJO, the percentage of variation was almost insignificant (0,19% for the 1:25 dilution and 1,50% for the 1:10 dilution), but became highly significant for the 1:5, 1:1, and undiluted samples. (6,87%, 12,03%, and 19,92% respectively). This shows that the antioxidant effect of the UBPJO is maintained up to 1:5 but diminishes after 1:10. Overall, the ΔOD values for UBPJO were 1.5 times higher than PJO (Figure 1C and D).

2.1.2. ABTS Method

ABTS antioxidant capacity assay was performed at multiple dilutions (1:1, 1:5, 1:10, and 1:25 in ethanol) to evaluate dose-response behavior. We were unable to assess the undiluted samples because an emulsification process rendered them unsuitable for reading at the specified OD. The literature indicates that the complex solubility of oil extracts with multiple components can skew results in ABTS assays (BenchChem Technical Support).
Results from the ABTS method show that the 1:1 dilution of UBPJO has the strongest antioxidant effect among all dilutions, while PJO is highly active at 1:5 and 1:10, consistently with no significant differences. At 45 minutes, the antioxidant effect reached its peak (ΔOD = 99.55% and 97.72%, respectively, Figure 2A). Furthermore, at all dilutions and times, ΔOD for PJO was approximately twice as high as for UBPJO (Figure 2A and B).
For UBPJO, the most pronounced reduction in optical density (ΔOD % at 734 nm) occurred at the 1:1 dilution; higher dilutions of UBPJO (1:5 to 1:25) showed progressively flatter responses (Figure 2B).
This pattern might indicate potent antioxidant activity, best captured at moderate dilution, where solubility issues in the undiluted oil are resolved without excessive dilution masking the effect.
The ABTS results show an optimal 1:1 dilution for the UBPJO, where maximum radical scavenging (ΔOD = 57.70% at 45 minutes) coincides with greater ethanol solubility (Figure 2B). This highlights the limitations of standard ABTS protocols for oils, as undiluted samples may limit antioxidant (e.g., tocopherols) access to the hydrophilic ABTS+ radical, leading to underestimated activity. The plateau at higher dilutions (>1:5) indicates the assay’s linear range is surpassed, confirming strong activity without a proportional dose-response, consistent with reports on oil plant extracts.
Results show that, for undiluted samples, an emulsification process occurred, which prevented accurate measurement of the high concentration of lipophilic compounds. This might be a limitation of the ABTS method in our experiment.

2.3. Sunscreen Properties

The calculated SPF for UBPJO was slightly higher than PJO (32.41 vs. 30.58); the results are shown comparatively with SPF values measured at wavelengths between 290 and 320 nm in Figure 3.

2.3. Antimicrobial Activity

The results of the antimicrobial activity assessment focused on two areas: determining the minimum inhibitory concentration (MIC) and evaluating the ability of PJO and UBPJO to inhibit microbial biofilm formation. To assess oil samples, we used a 20% Tween 80 solution in ethanol for solubilization, allowing the compounds to disperse in the aqueous culture medium. Tween 80 was included as a positive control in the microbiological analyses.
Data from Table 2 and Figure 4A show that UBPJO is significantly more effective than PJO against S. Aureus and C. Albicans, as evidenced by lower MIC values (p < 0.05). On E. Coli, T80 has the highest antifungal effect (p > 0.05).
Figure 4B and 4C show the ability of PJO and UBPJO to inhibit biofilm formation by the microbial strains tested at subinhibitory concentrations of MIC/2 and MIC/4.
PJO has an increased ability to inhibit the adhesion of E coli to the inert substrate than UBPJO at MIC/2 and MIC/4 (66.2 ± 51.18 and 31.34 ± 7.79 vs. 46.17 ± 12.84 and 19.25 ± 7.36, p > 0.05, Figure 4B and C).
Conversely, UBPJO at MIC/2 exhibited substantial antibiofilm activity against S. aureus (224.63 ± 2.85 vs. 7.95 ± 5.11, p < 0.001). Significantly higher activity was exhibited at M/4 (35.01 ± 8.47 vs. 7.87 ± 3.12, p < 0.01, Figure 4B and C).
The UBPJO extends the antibiofilm activity to C. albicans at MIC/2 more than PJO (63.75 ± 32.66 vs. 30.99 ± 18.42, p > 0.05).

3. Discussions

The current study examined a complex oil extract of U. barbata in Jojoba oil, enriched with 5% PEO and 10% Vitamin E, for potential skincare uses. The results show synergistic interactions among all active ingredients, yielding beneficial pharmacological properties (antioxidant, photoprotective, and antimicrobial) for this innovative formulation.
Before analyzing the contribution of each component, it is important to recognize that synergy in cosmetic formulations occurs when the combined effect of ingredients exceeds the sum of their individual effects. Each ingredient in this group functions through distinct but complementary biochemical mechanisms, providing multi-layered protection and effectiveness.
Vitamin E serves as the cornerstone of antioxidant synergy in this formulation system, and its contributions are well documented [66]. It donates a hydrogen atom to stabilize free radicals generated by UV exposure, pollution, or oxidative stress [67]. However, in doing so, it becomes a tocopheroxyl radical itself — relatively stable due to its aromatic nature, but no longer active [68,69].
Vitamin E is found in lipid membranes [70,71] and is the first barrier to neutralize free radicals produced by UV radiation [72,73]. During this process, it becomes oxidized and forms a less active radical [74]. Vitamin E primarily functions in the lipid phase, which directly relates to its interaction with jojoba oil, as a lipid-rich carrier.
Topical application of alpha-tocopherol (the active form of vitamin E) has been shown to increase collagen density during the early phase of wound healing, with a significant rise in fibroblast numbers observed in treated animals compared to placebo [75,76]. Vitamin E can also serve as a cofactor to stabilize Vitamin A and protect it from oxidation, suggesting a broader role as a molecular protector of other sensitive actives within a formulation [73,77].
Jojoba oil is not a typical triglyceride oil — its structure closely resembles that of liquid wax, which gives it excellent oxidative stability, high skin compatibility, and greater stability than regular oils [78]. This wax-like structure makes jojoba oil an ideal lipid-phase carrier for fat-soluble ingredients like Vitamin E and components of peppermint oil. The liquid wax structure of jojoba oil stabilizes lipid-soluble actives, such as Vitamin E and terpenoids from peppermint essential oil [79].
The skin compatibility of JO enhances the penetration and bioavailability of co-ingredients [80]. Since Vitamin E functions within the lipid phase, jojoba oil’s wax-like lipid matrix provides an ideal environment for Vitamin E to act as an antioxidant at the membrane level. This shows that jojoba oil not only carries Vitamin E but also creates a supportive environment for its activity. It also enhances the synthesis of collagen and hyaluronic acid and diminishes inflammation in human skin [81]
The oxidative resilience of JO decreases the oxidative degradation of sensitive ingredients [82]. Moreover, due to its emollient properties, JO creates a protective film that prolongs the contact time of antimicrobial agents [83,84].
Peppermint oil’s antimicrobial properties complement Usnea barbata’s secondary metabolites activity. While usnic acid and other phenolic metabolites target bacterial cell membranes and metabolic processes, peppermint oil’s terpenoids disrupt microbial membrane integrity through a different but complementary pathway, potentially broadening the spectrum of antimicrobial coverage.
Menthol is a well-recognized skin penetration enhancer [85]. By temporarily modifying the lipid structure of the stratum corneum [85,86,87], peppermint oil can increase the bioavailability of vitamin E in deeper skin layers, enhance the delivery of usnic acid from U. barbata, and improve the overall efficacy of the formulation system [88].
Peppermint oil’s cooling and anti-inflammatory properties [89] complement Vitamin E’s documented anti-inflammatory effects [90]. Studies have shown that Vitamin E in combination with other actives leads to significant decreases in TNF-α expression [91], and peppermint oil’s menthol component activates TRPM8 receptors [92], providing an additional, mechanistically distinct anti-inflammatory pathway.
U. barbata contains phenolic secondary metabolites with particular structures; usnic acid is its primary bioactive compound [93].
Usnic acid disrupts bacterial DNA and RNA synthesis and membrane function [94]. When combined with peppermint oil’s membrane-disrupting terpenoids [95]. The two agents attack microbial cells through dual mechanisms, potentially reducing the minimum inhibitory concentration (MIC) required for each one — a classic definition of antimicrobial synergy.
Usnic acid possesses its own antioxidant properties through phenolic hydroxyl groups that can scavenge free radicals [96]. This creates a multi-molecular antioxidant network in combination with Vitamin E, resulting in broader radical-scavenging coverage.
Usnic acid has demonstrated UV-absorbing capacity [97], particularly in the UVB range. This complements Vitamin E’s photoprotective role (which is antioxidant-based rather than UV-filtering) [98] creating a two-pronged photoprotection system: U. barbata absorbs/filters UV photons [99], while vitamin E neutralizes reactive oxygen species generated by UV that pass through [100].
Antioxidant assays such as ABTS (2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) and DPPH (2,2-diphenyl-1-picrylhydrazyl) are commonly employed to evaluate the quality of oil extracts, particularly those rich in lipophilic compounds like tocopherols, carotenoids, and phenolic lipids derived from plants or marine sources. In oil matrices, DPPH often outperforms ABTS due to its superior solubility in non-polar solvents such as ethanol, hexane, or chloroform, enabling direct assessment of antioxidants without extensive emulsification or dilution that could skew results in ABTS assays. This makes DPPH particularly suitable for routine quality control in oil extract manufacturing, where rapid, reproducible measurements of radical-scavenging capacity are prioritized over absolute quantification.
Conversely, ABTS requires the generation of the radical cation (ABTS- +) in aqueous or mixed solvent systems, which may pose challenges for oil extracts; poor solubility might lead to an underestimation of lipophilic antioxidants and higher variability.
Research on essential and vegetable oil supplements shows that DPPH provides more consistent results than ABTS, often indicating 1.5-2 times higher capacities but with weaker correlation with in vivo bioactivity because it is sensitive to both hydrophilic and lipophilic substances. Therefore, for oil extracts, DPPH is the preferred method for reliable quality assessment, offering practicality and specificity for lipophilic antioxidants, while ABTS can be used as a complementary tool for broader profiling when solubility issues are addressed [101].
The determination of the sun protection factor (SPF) for vegetable oils used in skincare products is a topic of intense investigation in the literature, highlighting significant variability in results across methodologies, concentrations, and formulation types [102,103,104,105,106,107,108,109,110]. Sun protection factor (SPF) is a quantitative indicator used in sunscreens to assess a formulation’s photoprotective efficacy against ultraviolet (UV) radiation.
In this study, both PJO and UBPJO were subjected to SPF determination by spectrophotometry. The results obtained indicated SPF values of ~30.58 for PJO and ~32.41 for UBPJO. These values demonstrate the ability of both formulations to act as natural photoprotective agents, and the smaller difference between the two confirms an increase in efficiency when using the combination with lichen extract.
In both oil samples, PJO and UBPJO, a progressive increase in absorbance towards lower wavenumbers (closer to 290 nm) was observed. This aligns with the literature, which indicates that the increased absorbance near 290 nm results from the higher-energy excitation of the conjugated π-electron system, a common absorption characteristic of phenols and other aromatic compounds, and matches the compositions of both samples determined in previous research. However, UBPJO shows slightly higher absorbance at all measured wavelengths than PJO, and this is due mainly to the synergistic interaction between the complex oil base’s bioactive compounds and the phenolic lichen secondary metabolites [111,112], including usnic acid [113]. U. barbata constituents ensure a higher concentration of chromophoric groups capable of absorbing UVB radiation. In addition to absorbing UV light directly, these phenolic compounds also have antioxidant properties. The dual function of these metabolites helps enhance photoprotection through two mechanisms:
o  
The absorption of UV photons is known as primary photoprotection. The energy is then dissipated through non-radioactive mechanisms [114].
o  
The active ROS (reactive oxygen species) neutralization is generated by UV exposure. This secondary photoprotection is also enhanced by the presence of alpha-tocopherol (the form of vitamin E) [115,116].
Pure vegetable oils generally exhibit low intrinsic SPF values, but they have recently been widely used in sunscreen formulations due to their unique UV-absorption properties and improvements in the spreadability and skin-adsorption characteristics of the final products [117,118]. The literature reports SPF values of 6.02 for JO, 9.28 for olive oil, 18.81 for carrot seed oil, and 22.04 for wheat germ oil [119] The SPF values of natural Jojoba oil reported in the literature are generally similar to those of other vegetable oils [120].
Montenegro et al. studied the use of 1% pomegranate and shea oil as natural UV filters to improve the SPF of sunscreen preparations [118]. Another recent study reported that the SPF of a cream base + Oksibenzon 2% + Octil metoximate 5% was significantly increased from 21.12 to 37.01 by adding 10% JO.
The SPF value of 30.58 for the PJO is consistent with literature data for vegetable oils combined with other compounds (PEO and vitamin E, as used in our research). The measured absorbance in the 290-330 nm spectral range can be attributed to the optical properties of the JO and PEO. Jojoba oil contributes to moderate UV absorption and, consequently, to a slight photoprotective activity, while PEO and vitamin E contribute to minor UV absorption and antioxidant activity.
Furthermore, the SPF value of 32.41 for UBPJO indicates that the U. barbata extract can moderately enhance the photoprotective performance and UV-absorbing capacity of formulations when they are incorporated into lipid-based matrices. Several studies have reported that usnic acid and other phenolic secondary metabolites of U. barbata exhibit antioxidant, anti-inflammatory, antiviral, and antimicrobial effects. These biological activities are particularly relevant for photoprotection because UV radiation induces oxidative stress and an anti-inflammatory skin response [99,121].
The antimicrobial activity was evaluated against the most common pathogens (S. aureus, E. coli, and C. albicans); our results revealed a significant antimicrobial and antibiofilm activity of UBPJO on S. aureus and C. albicans. The antimicrobial potential of UBPJO is mainly due to the synergistic action of its 2 ingredients, U. barbata and PEO.
U. barbata efficacy against S. aureus is mainly due to phenolic secondary metabolites, especially usnic acid [33,34]. Usnic acid’s anti-staphylococcal activity involves a multitarget approach. It primarily disrupts the bacterial cell membrane, rapidly inhibits RNA, DNA, and protein synthesis, and impairs peptidoglycan/fatty acid biosynthesis [122]. Moreover, usnic acid can inhibit multidrug resistance (MDR) efflux pumps, reducing MRSA’s ability to expel antibiotics and thereby increasing its sensitivity to drugs such as vancomycin and norfloxacin. disrupts pre-formed biofilms and inhibits the formation of new ones by reducing surface attachment and inhibiting bacterial quorum sensing [122,123].
Our previous research reported a strong antibacterial and antibiofilm activity of Peppermint essential oil from Fares S.A. against S. aureus [124]. The results align with those of other studies from the scientific literature [125,126]. Thus, PEO demonstrates significant potential as an antibacterial and anti-biofilm agent against S. aureus. PEO appears to cause irreversible damage to the cell membranes, as evidenced by increased membrane permeability and leakage of nucleic acids, proteins, and ATP. Additionally, PEO can inactivate mature S. aureus biofilms, highlighting its promising role in managing bacterial infections and biofilm-related challenges [46]. UBPJO is rich in pulegone (41.66%) and isomenthone (19.50%); both are very effective against S. aureus and act through a common mechanism of terpenoids [127,128,129].
Jojoba oil could also contribute to the inhibitory activity against S. aureus, according to Al-Ghamdi et al. [130].
According to the previously published studies [131,132,133,134], the key mechanisms of action of usnic acid against C. albicans include the following:
o  
Anti-biofilm activity: usnic acid reduces the biomass and thickness of mature biofilms, reducing metabolic activity in sessile cells.
o  
Inhibition of morphological transition: It restricts the transformation from yeast to hyphae, a critical stage in C. albicans infection and virulence.
o  
Oxidative/nitrosative stress: usnic acid induces both intracellular and extracellular reactive oxygen species, leading to cell damage.
o  
Reduced exopolysaccharide layer (EPS): It lowers the sugar content within the biofilm’s protective exopolysaccharide layer.
o  
Targeting drug-resistant strains: It shows efficacy against azole-resistant C. albicans.
The lipophilic characteristics of PEO, particularly its primary component menthol, facilitate its integration into the fungal phospholipid bilayer. This interaction induces significant alterations in membrane fluidity and permeability, leading to the leakage of essential intracellular constituents, including calcium, potassium, and magnesium ions; proteins; and nucleic acids. Consequently, these alterations lead to cellular death. Peppermint oil effectively diminishes the ergosterol content in fungal cell membranes. Ergosterol is a fundamental component of membrane stability; thus, its reduction undermines membrane integrity [135,136,137,138]. PEO has demonstrated the capability to completely inhibit C. albicans biofilm formation, thereby preventing the growth and survival of these pathogenic yeast strains [136]. PEO has been shown to stimulate ROS production, leading to oxidative damage to various cellular components, underscoring the importance of understanding its effects on cell health. Elevated ROS levels can damage DNA, leading to fragmentation. This process can trigger apoptosis-like cell death in fungi such as C. albicans, underscoring the potential implications of peppermint oil for antifungal applications [135,137]. Moreover, PEO can interfere with mitochondrial energy metabolism by inhibiting respiratory enzymes, thereby reducing ATP production in fungal cells [133,139,140].

4. Materials and Methods

4.1. Materials

Jojoba oil (JO) obtained by cold pressing Simmondsia chinensis seeds and Vitamin E were supplied by Fagron Hellas (Trikala, Greece). Jojoba oil is highly pure and suitable for cosmetic applications. Its liquid wax composition, primarily long-chain esters, provides oxidative stability, a non-greasy texture, and compatibility with human skin. In our experiment, it was combined with 10% Vitamin E.
Peppermint essential oil (PEO) was purchased from Fares S.A. Orastie; its CG-MS analysis was previously reported [58]. It was diluted in JO (carrier oil) mixed with 10% Vitamin E to 5% concentration (PJO).
U. barbata lichen was harvested in March 2024 from the Călimani Mountains, Romania (47°28′ N, 25°13′ E, at an altitude of 900 m). The freshly collected lichen thalli were separated from impurities, then dried at 18–25 °C in an herbal room, protected from sunlight. Dried lichen preservation for an extended period was performed in similar conditions. It was identified by the Department of Pharmaceutical Botany of the Faculty of Pharmacy at Carol Davila University of Medicine and Pharmacy using standard methods. A voucher specimen is maintained in the Herbarium of the Pharmacognosy Department, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy (UBL 3/2024, Ph-UMFCD) [29].
All chemicals, solvents, and reagents were of analytical grade.

4.2. Preparation of U. barbata Oil Extract

The oil extract was prepared by cold maceration, which preserves the integrity of bioactive compounds and prevents thermal degradation. The harvested lichen samples were ground and passed through successive 2.5 mm sieves (DIN 1171) and 1.2 mm mesh (DIN 117) for homogenization. Almost 20 g of this mass was accurately weighed using a Kern analytical balance, placed in a 1000 mL brown glass container, and 500 mL of JO enriched with 5% PEO and 10% Vitamin E was added. The sample was macerated for 3 months in a light-protected location at a constant temperature (21-22 °C) [41].
The brown container with both components was manually shaken daily for three months; after this period, the oil extract (UBPJO) was filtered into a brown vessel with a sealed plug and preserved in a plant room, sheltered from sunlight [41].

4.3. Antioxidant Activity

4.3.1. DPPH Method

We tested the radical-scavenging capacity of the UBPJO using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, as previously described [141,142,143]. The DPPH method is based on the discoloration of a solution containing the DPPH free radical (Sigma-Aldrich, USA) upon interaction with antioxidants present in the tested sample. For each sample, several dilutions in methanol were prepared (1:1, 1:5, 1:10, and 1:25) to assess the dose dependency of the antioxidant effect.
Each sample was used at a 1:2 ratio with the DPPH working solution, which had an initial OD of approximately 0.8.
We performed a kinetic assessment, recording the decrease in OD at 517 nm over 1 hour. Also, we conducted endpoint measurements, after an incubation period of 5, 30, and 60 min respectively, analyzing the decrease of OD:
ΔOD (%) = 100 × (OD DPPH + sample – OD sample)/OD DPPH.
This was considered to express the antioxidant effect of the tested oil samples.

4.3.2. ABTS Method

We used an ABTS (2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid))-based method to assess the antioxidant capacity of the extract [141]. This method is based on measuring the sample’s scavenging capacity of the ABTS+∙ free radical. The stock reagent containing ABTS 7mM and K2S2O8 2.45mM was kept in the dark for 16 h at 4 °C for the generation of the green ABTS+∙ free radical. The working solution (WS) was obtained by diluting the stock with distilled water until an appropriate OD (0.8) was reached at 714 nm.
Samples (undiluted as well as 1:1, 1:5, 1:10, and 1:25 dilutions) were incubated with ABTS WS in a 1:3 ratio, and OD was measured at 714 nm after an incubation period of 10 min. A blank was prepared using ethanol instead of the sample. Results are presented as the % decrease of optical density (ΔOD):
ΔOD (%) = 100 × (OD blank – OD sample)/OD blank.
These are directly correlated to the antioxidant capacity of the samples.

4.4. Sunscreen Properties

1 mL of each oil sample was added to a 100 mL volumetric flask and diluted with ethanol to the mark. Further, it was ultrasonicated for 5 min. The sun protection factor (SPF) of the oil samples was determined using a Perkin-Elmer Lambda 35 UV-Vis spectrophotometer (Perkin-Elmer Inc., Waltham, MA, USA) in transmission mode. Oil samples were placed in microcuvettes with a 10 mm light path, and absorbance spectra were recorded over 290-320 nm at 5 nm intervals, with three determinations at each point. SPF values were calculated according to established protocols using the Mansur formula [144,145,146,147,148,149,150,151,152] (Eq 1).
S P F = C F × 320 290 E E λ × I λ × a b s λ
where CF is the correction factor (usually, CF=10), EE(λ) is the erythemogenic effect of radiation at wavelength λ, I(λ) is the intensity of solar light at wavelength λ, and abs (λ) is the absorbance of wavelength λ by the preparation solution.

4.5. Antimicrobial Activity

To evaluate the antimicrobial activity of PJO and UBPJO, we determined the minimum inhibitory concentration (MIC) and the adhesion capacity of the strains to an inert substrate (PICA% = percentage inhibition of adhesion capacity), using the following reference strains purchased from American Type Culture Collection (ATCC): Staphylococcus aureus ATCC 25923, Escherichia coli ATCC25922, and Candida albicans ATCC10231.

4.5.1. Determination of Minimum Inhibitory Concentrations

Suspensions with an optical density of 0.5 McFarland for bacteria and 1 McFarland for fungi were prepared, and the following were distributed in the 96-well plates: 100 μL of TSA (Tryptic Soy Agar, Sigma-Aldrich Merck (Dartmand, Germany) liquid culture medium (for bacteria) and RPMI 1640 (American Biorganics, Buffalo, NY, USA) (for fungi), 100 μL of a 100 mg/ml solution of the substances investigated in the first well, after which a binary serial dilution scheme was performed up to well 10, and 20 μL of suspension from the strains to be analyzed, from well 1 to well 11 (11 representing the positive growth control, and 12 representing the negative control). The samples were processed in duplicate. The absorbance readings were performed at 620 nm using a Thermo Scientific™ Multiskan™ GO Microplate Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) [153].

4.5.2. Evaluation of the Influence of Oil Samples on Microbial Adherence Capacity to the Inert Substratum

The influence of UBPJO and PJO on biofilm formation is evaluated using the previously described method to determine MIC values. After reading these values, the degree of adhesion to the inert substrate of the tested strains is evaluated by following these steps: fixation with methanol, staining with 1% crystal violet solution resuspended in 33% acetic acid.
The percentage of capacity of adherence inhibition (%) was determined using the following formula:
ACIP (%) = (As − Ablank) × 100/(Ac − Ablank)
where As is the absorbance at 490 nm of the tested samples, and Ac is the absorbance at 490 nm of the control [153].

4.6. Data Analysis

Almost all measurements were performed in triplicate to ensure reproducibility, and the results are expressed as mean ± standard deviation. Data analysis was performed using XLSTAT Premium v.2025.2.0.1232 (Lumivero, Denver, CO, USA) and Microsoft Excel v. 16.0 19328 (Microsoft Corporation, Redmond, WA, USA). ANOVA single factor was used to detect significant differences between variables (p < 0.05) [124].

5. Conclusions

The present study investigated the antioxidant, photoprotective, and antimicrobial properties of a complex oil lichen extract, U. barbata in Jojoba oil enriched with 5% Peppermint essential oil and 10% Vitamin E, with potential applications in the cosmetic field. The results suggest synergy between the active ingredients across all evaluated pharmacological activities. UBPJO offers promising perspectives for the further development of multifunctional formulations that could protect the skin against oxidative stress and UV radiation, maintain hydration, and support skin health through antioxidant and antimicrobial properties.
In the future, advanced studies may focus on incorporating UBPJO into various cosmetic formulations to investigate its properties and valorize its benefits in a skincare routine or in the therapy of various skin conditions.

Author Contributions

Conceptualization, M.A.D., E.A.O., V.P., and D.L.; methodology, M.A.D., M.I.N., E.A.O., A.U., A.R.U., V.P., A.M.M., V.B., A.L.A. and D.M.; software, V.P.; validation, E.A.O., A.M.M., A.L.A., D.L., and D.M.; formal analysis, V.P.; investigation, M.A.D., M.I.N., E.A.O., A.U., A.R.U., V.P., A.M.M., V.B., R.G.C., A.L.A., D.L. and D.M.; resources, M.A.D., M.I.N., E.A.O., A.U., A.R.U., V.P., A.M.M., V.B., R.G.C., A.L.A., D.L. and D.M.; data curation, M.A.D., M.I.N., E.A.O., A.U., A.R.U., V.P., A.M.M., V.B., R.G.C., A.L.A., D.L. and D.M.; writing—original draft preparation, M.A.D., M.I.N., E.A.O., A.U., A.R.U., V.P., A.M.M., V.B., R.G.C., A.L.A., D.L. and D.M.; writing—review and editing, E.A.O., V.P., A.M.M., and D.M.; visualization, M.A.D., M.I.N., E.A.O., A.U., A.R.U., V.P., A.M.M., V.B., R.G.C., A.L.A., D.L. and D.M.; supervision, D.L.; project administration, D.L.; funding acquisition, E.A.O. and R.G.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the manuscript text.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Zhang, L.; Adique, A.; Sarkar, P.; Shenai, V.; Sampath, M.; Lai, R.; Qi, J.; Wang, M.; Farage, M.A. The Impact of Routine Skin Care on the Quality of Life. Cosmetics 2020, 7, 59. [Google Scholar] [CrossRef]
  2. Yin, L.; Morita, A.; Tsuji, T. Skin Aging Induced by Ultraviolet Exposure and Tobacco Smoking: Evidence from Epidemiological and Molecular Studies. Photodermatol. Photoimmunol. Photomed. 2001, 17, 178–183. [Google Scholar] [CrossRef]
  3. RITTIE, L. UV-Light-Induced Signal Cascades and Skin Aging. Ageing Res. Rev. 2002, 1, 705–720. [Google Scholar] [CrossRef]
  4. Amaro-Ortiz, A.; Yan, B.; D’Orazio, J. Ultraviolet Radiation, Aging and the Skin: Prevention of Damage by Topical CAMP Manipulation. Molecules 2014, 19, 6202–6219. [Google Scholar] [CrossRef]
  5. Engel, K.; Schmidt, U.; Reuter, J.; Weckesser, S.; Simon-Haarhaus, B.; Schempp, C.M. Usnea Barbata Extract Prevents Ultraviolet-B Induced Prostaglandin E2 Synthesis and COX-2 Expression in HaCaT Keratinocytes. J. Photochem. Photobiol. B 2007, 89. [Google Scholar] [CrossRef]
  6. Vats, K.; Kruglov, O.; Mizes, A.; Samovich, S.N.; Amoscato, A.A.; Tyurin, V.A.; Tyurina, Y.Y.; Kagan, V.E.; Bunimovich, Y.L. Keratinocyte Death by Ferroptosis Initiates Skin Inflammation after UVB Exposure. Redox Biol. 2021, 47, 102143. [Google Scholar] [CrossRef] [PubMed]
  7. Abdul Aziz, M.W.H.; Basri, D.F.; Masre, S.F.; Ghazali, A.R. UVB Induced Skin Cancer Development in Experimental Mouse Model: A Review. Malaysian Journal of Fundamental and Applied Sciences 2023, 19, 754–761. [Google Scholar] [CrossRef]
  8. Farida, V.; Dewananda, D.A.; Sahid, M.N.A.; Salasia, S.I.O. Ultraviolet B (UVB) Radiation Induces Skin Alterations, Emperipolesis and Decreases the Erythroid-to-Myeloid Ratio in Rats. The Indonesian Biomedical Journal 2024, 16, 510–516. [Google Scholar] [CrossRef]
  9. Tyagi, N.; Bhardwaj, A.; Srivastava, S.K.; Arora, S.; Marimuthu, S.; Deshmukh, S.K.; Singh, A.P.; Carter, J.E.; Singh, S. Development and Characterization of a Novel in Vitro Progression Model for UVB-Induced Skin Carcinogenesis. Sci. Rep. 2015, 5, 13894. [Google Scholar] [CrossRef]
  10. Lan, C.-C.E.; Hung, Y.-T.; Fang, A.-H.; Ching-Shuang, W. Effects of Irradiance on UVA-Induced Skin Aging. J. Dermatol. Sci. 2019, 94, 220–228. [Google Scholar] [CrossRef] [PubMed]
  11. Battie, C.; Jitsukawa, S.; Bernerd, F.; Del Bino, S.; Marionnet, C.; Verschoore, M. New Insights in Photoaging, UVA Induced Damage and Skin Types. Exp. Dermatol. 2014, 23, 7–12. [Google Scholar] [CrossRef]
  12. Quintero-Ruiz, N.; Corradi, C.; Moreno, N.C.; de Souza, T.A.; Menck, C.F.M. UVA-Light-Induced Mutagenesis in the Exome of Human Nucleotide Excision Repair-Deficient Cells. Photochemical & Photobiological Sciences 2025, 24, 429–449. [Google Scholar] [CrossRef]
  13. Cadet, J.; Douki, T. Formation of UV-Induced DNA Damage Contributing to Skin Cancer Development. Photochemical & Photobiological Sciences 2018, 17, 1816–1841. [Google Scholar] [CrossRef]
  14. Criton, V.J.S.; Joy, S. Beyond Skincare Routines: Follow Your Gut to Healthy Skin – A Review of the Interplay between Gut Microbiome and Skin. Journal of Skin and Sexually Transmitted Diseases 2024, 6, 5. [Google Scholar] [CrossRef]
  15. Messaraa, C.; Robertson, N.; Walsh, M.; Hurley, S.; Doyle, L.; Mansfield, A.; Daly, L.; Tansey, C.; Mavon, A. Clinical Evidences of Benefits from an Advanced Skin Care Routine in Comparison with a Simple Routine. J. Cosmet. Dermatol. 2020, 19, 1993–1999. [Google Scholar] [CrossRef]
  16. Amartey, E.O.; Asumadu-Sakyi, A.B.; Adjei, C.A.; Quashie, F.K.; Duodu, G.O.; Bentil, N.O. Determination of Heavy Metals Concentration in Hair Pomades on the Ghanaian Market Using Atomic Absorption Spectrometry Technique. British Journal of Pharmacology and Toxicology 2011, 2. [Google Scholar]
  17. Amuah, Ebenezer Ebo Yahans; Antwi, Kwabena; Ankamah, Nelson Awuah. Elemental Burdens of Cosmetics and Associated Health and Environmental Impacts: A Global View. World Journal of Advanced Research and Reviews 2023, 20. [Google Scholar] [CrossRef]
  18. J. N., O. Possible Health Implications Associated with Cosmetics: A Review. Science Journal of Public Health 2015, 3, 58. [CrossRef]
  19. Wang, M.T.; Craig, J.P. Investigating the Effect of Eye Cosmetics on the Tear Film: Current Insights. Clin. Optom. (Auckl). 2018, Volume 10, 33–40. [Google Scholar] [CrossRef] [PubMed]
  20. Pollock, S.; Taylor, S.; Oyerinde, O.; Nurmohamed, S.; Dlova, N.; Sarkar, R.; Galadari, H.; Manela-Azulay, M.; Chung, H.S.; Handog, E.; et al. The Dark Side of Skin Lightening: An International Collaboration and Review of a Public Health Issue Affecting Dermatology. Int. J. Womens Dermatol. 2021, 7, 158–164. [Google Scholar] [CrossRef] [PubMed]
  21. Sami Alyahya, R.; AlHasson, M.A.; Ali Alhsaon, M.A. Assessing the Adverse Effects and Safety Concerns Related to Cosmetic and Skincare Products: A Systematic Review. Cureus 2025. [Google Scholar] [CrossRef]
  22. Alblooshi, S. The Impact of Perfumes and Cosmetic Products on Human Health: A Narrative Review. Frontiers in Toxicology 2025, 7. [Google Scholar] [CrossRef]
  23. Bilal, M.; Mehmood, S.; Iqbal, H.M.N. The Beast of Beauty: Environmental and Health Concerns of Toxic Components in Cosmetics. Cosmetics 2020, 7, 13. [Google Scholar] [CrossRef]
  24. Jha, A.; Jha, M. The Hidden Dangers: How Synthetic Organic Compounds Impact Health and the Environment. International Journal of Nursing Information 2024, 3, 9–21. [Google Scholar] [CrossRef]
  25. Marchev, A.S.; Georgiev, M.I. Plant in Vitro Systems as a Sustainable Source of Active Ingredients for Cosmeceutical Application. Molecules 2020, 25. [Google Scholar] [CrossRef] [PubMed]
  26. Wawoczny, A.; Gillner, D. The Most Potent Natural Pharmaceuticals, Cosmetics, and Food Ingredients Isolated from Plants with Deep Eutectic Solvents. J. Agric. Food Chem. 2023, 71, 10877–10900. [Google Scholar] [CrossRef]
  27. Shahanawaz, Mo.; Singh, K.; Suvaiv; Kushwaha, S.P.; Kumar, A.; Ahmad, S. Natural Ingredients in Pharmaceutical Technology for Cosmetics. In The Impact of Pharma Technology on Cosmetics: Advancements and Innovations; BENTHAM SCIENCE PUBLISHERS, 2025; pp. 128–163. [Google Scholar]
  28. Kumar Dwivedi Research Scholar, A.; Satya Sai, S.; Jhade Associate Professor, D.; Satya, S.; Kumar Dwivedi, A.; Jhade, D. Cosmetic Potential of Selected Medicinal Plants: A Review. ~ 381 ~ Journal of Pharmacognosy and Phytochemistry 2021, 10. [Google Scholar]
  29. Babich, O.; Ivanova, S.; Bakhtiyarova, A.; Kalashnikova, O.; Sukhikh, S. Medicinal Plants Are the Basis of Natural Cosmetics. Process Biochemistry 2025, 154, 35–51. [Google Scholar] [CrossRef]
  30. Popovici, V.; Bucur, L.; Popescu, A.; Schröder, V.; Costache, T.; Rambu, D.; Cucolea, I.E.; Gîrd, C.E.; Caraiane, A.; Gherghel, D.; et al. Antioxidant and Cytotoxic Activities of Usnea Barbata (L.) F.H. Wigg. Dry Extracts in Different Solvents. Plants 2021, 10, 909. [Google Scholar] [CrossRef] [PubMed]
  31. Popovici, V.; Bucur, L.; Costache, T.; Gherghel, D.; Vochita, G.; Mihai, C.T.; Rotinberg, P.; Schroder, V.; Badea, F.C.; Badea, V. Studies on Preparation and UHPLC Analysis of the Usnea Barbata (L) F.H.Wigg Dry Acetone Extract. Revista de Chimie 2019, 70, 3775–3777. [Google Scholar] [CrossRef]
  32. Popovici, V.; Bucur, L.A.; Schröder, V.; Gherghel, D.; Mihai, C.T.; Caraiane, A.; Badea, F.C.; Vochița, G.; Badea, V. Evaluation of the Cytotoxic Activity of the Usnea Barbata (L.) F. H. Wigg Dry Extract. Molecules 2020, 25, 1865. [Google Scholar] [CrossRef]
  33. Popovici, V.; Bucur, L.; Gîrd, C.E.; Popescu, A.; Matei, E.; Caraiane, A.; Botnarciuc, M. Phenolic Secondary Metabolites and Antiradical and Antibacterial Activities of Different Extracts of Usnea Barbata (L.) Weber Ex F. H. Wigg from C ă Limani Mountains, Romania. Pharmaceuticals 2022, 15, 829. [Google Scholar] [CrossRef] [PubMed]
  34. Popovici, V.; Bucur, L.; Calcan, S.I.; Cucolea, E.I.; Costache, T.; Rambu, D.; Schröder, V.; Gîrd, C.E.; Gherghel, D.; Vochita, G.; et al. Elemental Analysis and In Vitro Evaluation of Antibacterial and Antifungal Activities of Usnea Barbata (L.) Weber Ex F.H. Wigg from C ă Limani Mountains, Romania. Plants 2022, 11, 32. [Google Scholar] [CrossRef]
  35. Popovici, V.; Bucur, L.; Gîrd, C.E.; Rambu, D.; Calcan, S.I.; Cucolea, E.I.; Costache, T.; Ungureanu-Iuga, M.; Oroian, M.; Mironeasa, S.; et al. Antioxidant, Cytotoxic, and Rheological Properties of Canola Oil Extract of Usnea Barbata ( L.) Weber Ex F. H. Wigg from Călimani Mountains, Romania. Plants 2022, 11, 854. [Google Scholar] [CrossRef]
  36. Popovici, V.; Matei, E.; Cozaru, G.C.; Aschie, M.; Bucur, L.; Rambu, D.; Costache, T.; Cucolea, I.E.; Vochita, G.; Gherghel, D.; et al. Usnic Acid and Usnea Barbata (L.) F.H. Wigg. Dry Extracts Promote Apoptosis and DNA Damage in Human Blood Cells through Enhancing ROS Levels. Antioxidants 2021, 10, 1171. [Google Scholar] [CrossRef]
  37. Popovici, V.; Matei, E.; Cozaru, G.C.; Bucur, L.; Gîrd, C.E.; Schröder, V.; Ozon, E.A.; Karampelas, O.; Musuc, A.M.; Atkinson, I.; et al. Evaluation of Usnea Barbata ( L.) Weber Ex F. H. Wigg Extract in Canola Oil Loaded in Bioadhesive Oral Films for Potential Applications in Oral Cavity Infections and Malignancy. Antioxidants 2022, 11, 1601. [Google Scholar] [CrossRef]
  38. Popovici, V.; Matei, E.; Cozaru, G.C.; Bucur, L.; Gîrd, C.E.; Schröder, V.; Ozon, E.A.; Musuc, A.M.; Mitu, M.A.; Atkinson, I.; et al. In Vitro Anticancer Activity of Mucoadhesive Oral Films Loaded with Usnea Barbata ( L. ) F. H. Wigg Dry Acetone Extract, with Potential Applications in Oral Squamous Cell Carcinoma Complementary Therapy. Antioxidants 2022, 11, 1934. [Google Scholar] [CrossRef] [PubMed]
  39. Popovici, V.; Matei, E.; Cozaru, G.; Bucur, L.; Gîrd, C.E.; Schröder, V.; Ozon, E.A.; Sarbu, I.; Musuc, A.M.; Atkinson, I.; et al. Formulation and Development of Bioadhesive Oral Films Containing Usnea Barbata ( L.) F. H. Wigg Dry Ethanol Extract ( F-UBE-HPC ) with Antimicrobial and Anticancer Properties for Potential Use in Oral Cancer Complementary Therapy. Pharmaceutics 2022, 14, 1808. [Google Scholar] [CrossRef] [PubMed]
  40. Popovici, V.; Matei, E.; Cozaru, G.C.; Bucur, L.; Gîrd, C.E.; Schröder, V.; Ozon, E.A.; Mitu, M.A.; Musuc, A.M.; Petrescu, S.; et al. Design, Characterization, and Anticancer and Antimicrobial Activities of Mucoadhesive Oral Patches Loaded with Usnea Barbata ( L.) F. H. Wigg Ethanol Extract F-UBE-HPMC. Antioxidants 2022, 11, 1801. [Google Scholar] [CrossRef]
  41. Dan, M.A.; Cioancă, O.; Popovici, V.; Musuc, A.M.; Nițulescu, G.M.; Anastasescu, M.; Ozon, E.A.; Marinas, I.C.; Guțu, C.M.; Baconi, D.L.; et al. Phytochemical Screening and Physicochemical Properties of Oil Extract of Usnea Barbata L. F.H.Wigg from Călimani Mountains, Romania. Int. J. Mol. Sci. 2026, 27. [Google Scholar] [CrossRef]
  42. Pazyar, N.; Yaghoobi, R.; Ghassemi, M.R.; Kazerouni, A.; Rafeie, E.; Jamshydian, N. Jojoba in Dermatology: A Succinct Review. Giornale Italiano di Dermatologia e Venereologia 2013, 148. [Google Scholar]
  43. Zhao, H.; Ren, S.; Yang, H.; Tang, S.; Guo, C.; Liu, M.; Tao, Q.; Ming, T.; Xu, H. Peppermint Essential Oil: Its Phytochemistry, Biological Activity, Pharmacological Effect and Application. Biomedicine & Pharmacotherapy 2022, 154, 113559. [Google Scholar] [CrossRef]
  44. Kazemi, A.; Iraji, A.; Esmaealzadeh, N.; Salehi, M.; Hashempur, M.H. Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations. Crit. Rev. Food Sci. Nutr. 2025, 65, 1553–1578. [Google Scholar] [CrossRef]
  45. Erawati, T.; Arifiani, R.A.; Miatmoko, A.; Hariyadi, D.M.; Rosita, N.; Purwanti, T. The Effect of Peppermint Oil Addition on the Physical Stability, Irritability, and Penetration of Nanostructured Lipid Carrier Coenzyme Q10. J. Public Health Afr. 2023, 14, 8. [Google Scholar] [CrossRef]
  46. Kang, J.; Jin, W.; Wang, J.; Sun, Y.; Wu, X.; Liu, L. Antibacterial and Anti-Biofilm Activities of Peppermint Essential Oil against Staphylococcus Aureus. LWT 2019, 101, 639–645. [Google Scholar] [CrossRef]
  47. Osawa, K.; Saeki, T.; Yasuda, H.; Hamashima, H.; Sasatsu, M.; Arai, T. The Antibacterial Activities of Peppermint Oil and Green Tea Polyphenols, Alone and in Combination, against Enterohemorrhagic Escherichia Coli. Biocontrol Sci. 1999, 4, 1–7. [Google Scholar] [CrossRef]
  48. Kehili, S.; Boukhatem, M.N.; Belkadi, A.; Ferhat, M.A.; Setzer, W.N. Peppermint (Mentha Piperita L.) Essential Oil as a Potent Anti-Inflammatory, Wound Healing and Anti-Nociceptive Drug. European Journal of Biological Research Research Article European Journal of Biological Research 2020, 10. [Google Scholar]
  49. Ilić, D.; Stanojević, J.; Cvetković, D.; Ristić, I.; Nikolić, V. Grinding of Serbian Peppermint (“Mentha” × ’Piperita L.’) Leaves: Variations Regarding Yield, Composition and Antimicrobial Activity of Isolated Essential Oil. Advanced Technologies 2022, 11, 5–12. [Google Scholar] [CrossRef]
  50. Joshi, M.; Hiremath, P.; John, J.; Ranadive, N.; Nandakumar, K.; Mudgal, J. Modulatory Role of Vitamins A, B3, C, D, and E on Skin Health, Immunity, Microbiome, and Diseases. Pharmacological Reports 2023, 75, 1096–1114. [Google Scholar] [CrossRef]
  51. Thiele, J.J.; Hsieh, S.N.; Ekanayake-Mudiyanselage, S. Vitamin E: Critical Review of Its Current Use in Cosmetic and Clinical Dermatology. Dermatol. Surg. 2005, 31. [Google Scholar] [CrossRef]
  52. Maulidiyah, *!!! REPLACE !!!*; Imran, *!!! REPLACE !!!*; Muntu, W.; Nurdin, M. Secondary Metabolites Identification from Lichen Usnea Longissima Ach.: Bioactivity Test of Antibacterial. International Journal of Applied Chemistry 2016. [Google Scholar]
  53. Sharma, B.C. Screening of Antioxidant Activity of Lichens Parmotrema Reticulatum and Usnea Sp. from Darjeeling Hills, India. IOSR Journal of Pharmacy (IOSRPHR) 2012, 2, 54–60. [Google Scholar] [CrossRef]
  54. Salgado, F.; Albornoz, L.; Cortéz, C.; Stashenko, E.; Urrea-Vallejo, K.; Nagles, E.; Galicia-Virviescas, C.; Cornejo, A.; Ardiles, A.; Simirgiotis, M.; et al. Secondary Metabolite Profiling of Species of the Genus Usnea by UHPLC-ESI-OT-MS-MS. Molecules 2018, 23, 54. [Google Scholar] [CrossRef]
  55. Maulidiyah, M.; Darmawan, A.; Ahmad, E.; Musdalifah, A.; Wibowo, D.; Salim, L.O.A.; Arham, Z.; Mustapa, F.; Nurdin, I.F.A.; Nurdin, M. Antioxidant Activity-Guided Isolation of Usnic Acid and Diffractaic Acid Compounds from Lichen Genus Usnea Sp. J. Appl. Pharm. Sci. 2021, 11, 075–083. [Google Scholar] [CrossRef]
  56. Popovici, V.; Bucur, L.; Vochita, G.; Gherghel, D.; Mihai, C.T.; Rambu, D.; Calcan, S.I.; Costache, T.; Cucolea, I.E.; Matei, E.; et al. In Vitro Anticancer Activity and Oxidative Stress Biomarkers Status Determined by Usnea Barbata (L.) f.h. Wigg. Dry Extracts. Antioxidants 2021, 10, 1141. [Google Scholar] [CrossRef] [PubMed]
  57. Popovici, V.; Musuc, A.M.; Matei, E.; Karampelas, O.; Ozon, E.A.; Cozaru, G.C.; Schröder, V.; Bucur, L.; Aricov, L.; Anastasescu, M.; et al. ROS-Induced DNA-Damage and Autophagy in Oral Squamous Cell Carcinoma by Usnea Barbata Oil Extract—An In Vitro Study. Int. J. Mol. Sci. 2022, 23, 14836. [Google Scholar] [CrossRef] [PubMed]
  58. Neagu, R.; Popovici, V.; Ionescu, L.-E.; Ordeanu, V.; Biță, A.; Popescu, D.M.; Ozon, E.A.; Gîrd, C.E. Phytochemical Screening and Antibacterial Activity of Commercially Available Essential Oils Combinations with Conventional Antibiotics against Gram-Positive and Gram-Negative Bacteria. Antibiotics 2024, 13, 478. [Google Scholar] [CrossRef]
  59. Popovici, V.; Bucur, L.; Popescu, A.; Caraiane, A.; Badea, V. Determination of the Content in Usnic Acid and Polyphenols from the Extracts of Usnea Barbata L. And the Evaluation of Their Antioxidant Activity. Farmacia 2018, 66, 337–341. [Google Scholar]
  60. Elečko, J.; Vilková, M.; Frenák, R.; Routray, D.; Ručová, D.; Bačkor, M.; Goga, M. A Comparative Study of Isolated Secondary Metabolites from Lichens and Their Antioxidative Properties. Plants 2022, 11, 1077. [Google Scholar] [CrossRef]
  61. Fernández-Moriano, C.; Pilar Gómez-Serranillos, M.; Crespo, A.; Gó Mez-Serranillos, M.P. Antioxidant Potential of Lichen Species and Their Secondary Metabolites. A Systematic Review. Pharm. Biol. 2016, 54, 1–17. [Google Scholar] [CrossRef] [PubMed]
  62. Žugić, A.; Tadić, V.; Kundaković, T.; Savić, S. Chemical Composition and Biological Activities of the Extracts and Secondary Metabolites of Lichens Belonging to the Genus Usnea, Parmeliaceae. Lekovite sirovine 2018, 38, 68–80. [Google Scholar] [CrossRef]
  63. Blaak, J.; Staib, P. An Updated Review on Efficacy and Benefits of Sweet Almond, Evening Primrose and Jojoba Oils in Skin Care Applications. Int. J. Cosmet. Sci. 2022, 44, 1–9. [Google Scholar] [CrossRef]
  64. Taha, S.H.; Abdel-Hamid, M.; Awad, A.A.; Elshaghabee, F.M.F. Extending the Shelf Life of Ghee Using Garden Cress and Jojoba Oils as Alternatives of Synthetic Antioxidants. Egypt. J. Chem. 2022, 65. [Google Scholar] [CrossRef]
  65. Rios-Estepa, R.; Turner, G.W.; Lee, J.M.; Croteau, R.B.; Lange, B.M. A Systems Biology Approach Identifies the Biochemical Mechanisms Regulating Monoterpenoid Essential Oil Composition in Peppermint. Proceedings of the National Academy of Sciences 2008, 105, 2818–2823. [Google Scholar] [CrossRef] [PubMed]
  66. Barouh, N.; Bourlieu-Lacanal, C.; Figueroa-Espinoza, M.C.; Durand, E.; Villeneuve, P. Tocopherols as Antioxidants in Lipid-based Systems: The Combination of Chemical and Physicochemical Interactions Determines Their Efficiency. Compr. Rev. Food Sci. Food Saf. 2022, 21, 642–688. [Google Scholar] [CrossRef] [PubMed]
  67. Miyazawa, T.; Burdeos, G.C.; Itaya, M.; Nakagawa, K.; Miyazawa, T. Vitamin E: Regulatory Redox Interactions. IUBMB Life 2019, 71, 430–441. [Google Scholar] [CrossRef]
  68. Kumar, A.; Prasad, A.; Pospíšil, P. Formation of α-Tocopherol Hydroperoxide and α-Tocopheroxyl Radical: Relevance for Photooxidative Stress in Arabidopsis. Sci. Rep. 2020, 10, 19646. [Google Scholar] [CrossRef] [PubMed]
  69. Mehlhorn, R.J.; Sumida, S.; Packer, L. Tocopheroxyl Radical Persistence and Tocopherol Consumption in Liposomes and in Vitamin E-Enriched Rat Liver Mitochondria and Microsomes. Journal of Biological Chemistry 1989, 264. [Google Scholar] [CrossRef]
  70. Konings, A.W.T.; Drijver, E.B. Radiation Effects on Membranes: I. Vitamin E Deficiency and Lipid Peroxidation. Radiat. Res. 1979, 80, 494. [Google Scholar] [CrossRef]
  71. Herrera, E.; Barbas, C. Vitamin E: Action, Metabolism and Perspectives. J. Physiol. Biochem. 2001, 57, 43–56. [Google Scholar] [CrossRef]
  72. Burke, K.E.; Clive, J.; Combs, G.F.; Commisso, J.; Keen, C.L.; Nakamura, R.M. Effects of Topical and Oral Vitamin E on Pigmentation and Skin Cancer Induced by Ultraviolet Irradiation in Skh:2 Hairless Mice. Nutr. Cancer 2000, 38, 87–97. [Google Scholar] [CrossRef] [PubMed]
  73. Bikiaris, N.D.; Koumentakou, I.; Hatzistamatiou, K.; Lykidou, S.; Barmpalexis, P.; Nikolaidis, N. Preparation and Investigation of the SPF and Antioxidant Properties of O/W and W/O Emulsions Containing Vitamins A, C and E for Cosmetic Applications. Cosmetics 2023, 10. [Google Scholar] [CrossRef]
  74. Önal, B.; Ergin, G. Antioxidative Effects of α-Tocopherol and Ascorbyl Palmitate on Thermal Oxidation of Canola Oil. Nahrung - Food 2002, 46. [Google Scholar] [CrossRef]
  75. Scherer Santos, J.; Diniz Tavares, G.; Nogueira Barradas, T. Vitamin E and Derivatives in Skin Health Promotion; 2021. [Google Scholar]
  76. Baumann, L.S.; Md, J.S. The Effects of Topical Vitamin E on the Cosmetic Appearance of Scars. Dermatologic Surgery 1999, 25, 311–315. [Google Scholar] [CrossRef] [PubMed]
  77. Thiele, J.J.; Ekanayake-Mudiyanselage, S. Vitamin E in Human Skin: Organ-Specific Physiology and Considerations for Its Use in Dermatology. Mol. Aspects Med. 2007, 28, 646–667. [Google Scholar] [CrossRef]
  78. Chakrabarty, S.; Jigdrel, K.; Mukherjee, P.; Paul, T.; Drakpa, D.; Gupta, J. Bioactivities of Jojoba Oil Beyond Skincare. J. Med. Food 2024, 27, 579–588. [Google Scholar] [CrossRef] [PubMed]
  79. Gad, H.A.; Roberts, A.; Hamzi, S.H.; Gad, H.A.; Touiss, I.; Altyar, A.E.; Kensara, O.A.; Ashour, M.L. Jojoba Oil: An Updated Comprehensive Review on Chemistry, Pharmaceutical Uses, and Toxicity. Polymers (Basel). 2021, 13. [Google Scholar] [CrossRef]
  80. Patzelt, A.; Lademann, J.; Richter, H.; Darvin, M.E.; Schanzer, S.; Thiede, G.; Sterry, W.; Vergou, T.; Hauser, M. In Vivo Investigations on the Penetration of Various Oils and Their Influence on the Skin Barrier. Skin Research and Technology 2012, 18, 364–369. [Google Scholar] [CrossRef]
  81. Tietel, Z.; Melamed, S.; Ogen-Shtern, N.; Eretz-Kdosha, N.; Silberstein, E.; Ayzenberg, T.; Dag, A.; Cohen, G. Topical Application of Jojoba (Simmondsia Chinensis L.) Wax Enhances the Synthesis of pro-Collagen III and Hyaluronic Acid and Reduces Inflammation in the Ex-Vivo Human Skin Organ Culture Model. Front. Pharmacol. 2024, 15. [Google Scholar] [CrossRef]
  82. Tsuchimoto, S.; Sakai, H.; Fukui, K. Oxidative Stability and Antioxidant Activity of Crude Jojoba Oil. BPB Reports 2022, 5. [Google Scholar] [CrossRef]
  83. Gruber, J. V; Terpak, N.; Massard, S.; Schwartz, A.; Bojanowski, K. Passive Enhancement of Retinol Skin Penetration by Jojoba Oil Measured Using the Skin Parallel Artificial Membrane Permeation Assay (Skin-PAMPA): A Pilot Study. Clin. Cosmet. Investig. Dermatol. 2023, Volume 16, 317–324. [Google Scholar] [CrossRef]
  84. Awad, N.A.; Eliraq, M.; El-Bassel, E.H.; Ismail, A.S.M.; Abd El-Aziz, Y.S.G.; Gawish, M.S.; Zewail, R.M.Y.; Sami, R.; Khojah, E.; Hilary, U.; et al. Evaluation of the Effect of Elite Jojoba Lineson the Chemical Properties of Their Seed Oil. Molecules 2022, 27. [Google Scholar] [CrossRef]
  85. Ahmad, N.; Nadeem, F.; Al-Sabahi, J.N.; Umar, A. Chemical Conversions of Essential Oil Components and Their Properties-A Review. IJCBS 2016, 9, 63–78. [Google Scholar]
  86. Das, S.; Sen Gupta, K. A Comprehensive Review on Natural Products as Chemical Penetration Enhancer. Journal of Drug Delivery and Therapeutics 2021, 11, 176–187. [Google Scholar] [CrossRef]
  87. Pandit, J.; Aqil, M.; Sultana, Y. Terpenes and Essential Oils as Skin Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement; Springer Berlin Heidelberg: Berlin, Heidelberg, 2015; pp. 173–193. [Google Scholar]
  88. Fox, L.T.; Gerber, M.; Du Plessis, J.; Hamman, J.H. Transdermal Drug Delivery Enhancement by Compounds of Natural Origin. Molecules 2011, 16, 10507–10540. [Google Scholar] [CrossRef]
  89. Goudarzi, M.A.; Radfar, M.; Goudarzi, Z. Peppermint as a Promising Treatment Agent in Inflammatory Conditions: A Comprehensive Systematic Review of Literature. Phytotherapy Research 2024, 38, 187–195. [Google Scholar] [CrossRef] [PubMed]
  90. Jiang, Q. Natural Forms of Vitamin E: Metabolism, Antioxidant, and Anti-Inflammatory Activities and Their Role in Disease Prevention and Therapy. Free Radic. Biol. Med. 2014, 72, 76–90. [Google Scholar] [CrossRef]
  91. Kuo, F.; Subramanian, B.; Kotyla, T.; Wilson, T.A.; Yoganathan, S.; Nicolosi, R.J. Nanoemulsions of an Anti-Oxidant Synergy Formulation Containing Gamma Tocopherol Have Enhanced Bioavailability and Anti-Inflammatory Properties. Int. J. Pharm. 2008, 363, 206–213. [Google Scholar] [CrossRef]
  92. Liu, B.; Fan, L.; Balakrishna, S.; Sui, A.; Morris, J.B.; Jordt, S.-E. TRPM8 Is the Principal Mediator of Menthol-Induced Analgesia of Acute and Inflammatory Pain. Pain 2013, 154, 2169–2177. [Google Scholar] [CrossRef]
  93. Ingólfsdóttir, K. Usnic Acid. Phytochemistry 2002, 61, 729–736. [Google Scholar] [CrossRef] [PubMed]
  94. Maciag-Dorszyńska, M.; Wegrzyn, G.; Guzow-Krzemińska, B. Antibacterial Activity of Lichen Secondary Metabolite Usnic Acid Is Primarily Caused by Inhibition of RNA and DNA Synthesis. FEMS Microbiol. Lett. 2014, 353, 57–62. [Google Scholar] [CrossRef]
  95. Yamaguchi, T. Antibacterial Effect of the Combination of Terpenoids. Arch. Microbiol. 2022, 204, 520. [Google Scholar] [CrossRef] [PubMed]
  96. Aslan Engin, T. Exploring the Antioxidant and Protective Effects of Usnic Acid: Opportunities and Challenges. Frontiers in Life Sciences and Related Technologies 2025, 6, 53–59. [Google Scholar] [CrossRef]
  97. Fernández, E.; Quilhot, W.; Rubio, C.; Hidalgo, M.E.; Diaz, R.; Ojeda, J. Effects of UV Radiation on Usnic Acid in Xanthoparmelia Microspora (Müll. Arg. Hale). Photochem. Photobiol. 2006, 82, 1065–1068. [Google Scholar] [CrossRef]
  98. Podhaisky, H.-P.; Wohlrab, W. Is the Photoprotective Effect of Vitamin E Based on Its Antioxidative Capacity? J. Dermatol. Sci. 2002, 28, 84–86. [Google Scholar] [CrossRef]
  99. Galanty, A.; Popiół, J.; Paczkowska-Walendowska, M.; Studzińska-Sroka, E.; Paśko, P.; Cielecka-Piontek, J.; Pękala, E.; Podolak, I. (+)-Usnic Acid as a Promising Candidate for a Safe and Stable Topical Photoprotective Agent. Molecules 2021, 26, 5224. [Google Scholar] [CrossRef]
  100. Offord, E.A.; Gautier, J.-C.; Avanti, O.; Scaletta, C.; Runge, F.; Krämer, K.; Applegate, L.A. Photoprotective Potential of Lycopene, β-Carotene, Vitamin E, Vitamin C and Carnosic Acid in UVA-Irradiated Human Skin Fibroblasts. Free Radic. Biol. Med. 2002, 32, 1293–1303. [Google Scholar] [CrossRef]
  101. Bibi Sadeer, N.; Montesano, D.; Albrizio, S.; Zengin, G.; Mahomoodally, M.F. The Versatility of Antioxidant Assays in Food Science and Safety—Chemistry, Applications, Strengths, and Limitations. Antioxidants 2020, 9, 709. [Google Scholar] [CrossRef]
  102. Situmorang, C.; Butar-Butar, M.E.T.; Sianturi, S. Effect of Sunflower Oil and Olive Oil Concentration on the Sunscreen Activity of Syzygium Myrtifolium Walp. Leaves Extract Cream. Pharmasipha: Pharmaceutical Journal of Islamic Pharmacy 2025, 9, 34–49. [Google Scholar] [CrossRef]
  103. Dewi, R.H.T.M.; Sholihah, N.; Nofitasari, R.; Adhityasmara, D.; Shabrina, A. The Potential of Avocado Oil for Topical Use: A Narrative Review. Jurnal Ilmu Farmasi dan Farmasi Klinik 2024, 21, 106. [Google Scholar] [CrossRef]
  104. Husen, R.A.; Zulkarnain, Z.; Sary, N.L.; Harnelly, E.; Husna, F. The Potential of Clove (Syzygium Aromaticum) Essential Oil as Sunscreen and Anti-Aging Agents: An In Vitro and In Silico Study. Trends in Sciences 2024, 21, 8209. [Google Scholar] [CrossRef]
  105. Ulandari Natasia, Y.; Wahyuni Nasution, S.; Suci, T. Test the Potential of Macadamia Nut Oil (Macadamia F. Muell) As Sunscreen in Cream Preparations In Vitro. International Journal of Health and Pharmaceutical (IJHP) 2022, 3. [Google Scholar] [CrossRef]
  106. Sutrisno; Abiq, M.A. Essential Oil of Elephant Ginger (Zingiber Officinale R.), Antioxidant and Sunscreen Activity and Its Formulation Tests as Sunscreen Cream. MALAYSIAN JOURNAL OF CHEMISTRY 2023, 25. [Google Scholar] [CrossRef]
  107. Ácsová, A.; Hojerová, J.; Janotková, L.; Bendová, H.; Jedličková, L.; Hamranová, V.; Martiniaková, S. The Real UVB Photoprotective Efficacy of Vegetable Oils: In Vitro and in Vivo Studies. Photochemical & Photobiological Sciences 2021, 20, 139–151. [Google Scholar] [CrossRef] [PubMed]
  108. Suiyarti, W.; Ervianingsih; Astari, C.; Riska; S, S. Determination of SPF (Sun Protection Factor) Value in Sunscreen Formulation of Vetiveria Zizanioides L. Essential Oil. Jurnal Penelitian Pendidikan IPA 2025, 11, 224–227. [Google Scholar] [CrossRef]
  109. Rastuti, U.; Widyaningsih, S.; Chasani, M.; Habibie, R.K.; Elly, V.F.R.; Zia, S.K. Formulation, Characterization, and Sunscreen Potential Evaluation of Nutmeg Leaf Essential Oil Nanoemulsions (Myristica Fragrans Houtt.). Molekul 2023, 18, 351. [Google Scholar] [CrossRef]
  110. Priani, S.E. Formulation and Characterization Sunscreen Emulgel Containing Cinnamon Bark Oil (Cinnamomum Burmannii Nees Ex Blume). Indonesian Journal of Pharmaceutical Science and Technology 2025, 12, 85–92. [Google Scholar] [CrossRef]
  111. Portilho, L.; Aiello, L.M.; Vasques, L.I.; Bagatin, E.; Leonardi, G.R. Effectiveness of Sunscreens and Factors Influencing Sun Protection: A Review. Brazilian Journal of Pharmaceutical Sciences 2022, 58. [Google Scholar] [CrossRef]
  112. Ng, S.Y.; Eh Suk, V.R.; Gew, L.T. Plant Polyphenols as Green Sunscreen Ingredients: A Systematic Review. J. Cosmet. Dermatol. 2022, 21, 5409–5444. [Google Scholar] [CrossRef]
  113. Varol, M.; Tay, T.; Candan, M.; Türk, A.; Koparal, A.T. Evaluation of the Sunscreen Lichen Substances Usnic Acid and Atranorin. Biocell 2015, 39, 25–31. [Google Scholar]
  114. Lal, R.; Kannaujiya, V.K. Green Photoprotective Chemicals: Diversity, Recent Developments, Challenges and Therapeutic Significance. Total Environment Microbiology 2025, 1, 100047. [Google Scholar] [CrossRef]
  115. Packer, L.; Valacchi, G. Antioxidants and the Response of Skin to Oxidative Stress: Vitamin E as a Key Indicator. Skin Pharmacol. Physiol. 2002, 15, 282–290. [Google Scholar] [CrossRef]
  116. Pincemail, J.; Meziane, S. On the Potential Role of the Antioxidant Couple Vitamin E/Selenium Taken by the Oral Route in Skin and Hair Health. Antioxidants 2022, 11, 2270. [Google Scholar] [CrossRef]
  117. Milutinov, J.; Pavlović, N.; Ćirin, D.; Atanacković Krstonošić, M.; Krstonošić, V. The Potential of Natural Compounds in UV Protection Products. Molecules 2024, 29, 5409. [Google Scholar] [CrossRef] [PubMed]
  118. Montenegro, L.; Santagati, L.M. Use of Vegetable Oils to Improve the Sun Protection Factor of Sunscreen Formulations. Cosmetics 2019, 6, 25. [Google Scholar] [CrossRef]
  119. Suryawanshi, J.A.S. IN-VITRO DETERMINATION OF SUN PROTECTION FACTOR AND EVALUATION OF HERBAL OILS. International Journal of Pharmacology Research 2016, 6, 37–43. [Google Scholar]
  120. Kaur, C.D.; Saraf, S. In Vitro Sun Protection Factor Determination of Herbal Oils Used in Cosmetics. Pharmacognosy Res. 2010, 2. [Google Scholar] [CrossRef]
  121. Yu, X.; Guo, Q.; Su, G.; Yang, A.; Hu, Z.; Qu, C.; Wan, Z.; Li, R.; Tu, P.; Chai, X. Usnic Acid Derivatives with Cytotoxic and Antifungal Activities from the Lichen Usnea Longissima. J. Nat. Prod. 2016, 79, 1373–1380. [Google Scholar] [CrossRef]
  122. Gangwar, B.; Kumar, S.; Kumar, P.; Pal, A.; Darokar, M.P. A Mechanistic Insight into the Anti-Staphylococcal Mode of Action of (+)-Usnic Acid and Its Synergy with Norfloxacin Against Methicillin-Resistant Staphylococcus Aureus. Biomolecules 2025, 15, 750. [Google Scholar] [CrossRef]
  123. Sinha, S.; Gupta, V.K.; Kumar, P.; Kumar, R.; Joshi, R.; Pal, A.; Darokar, M.P. Usnic Acid Modifies MRSA Drug Resistance through Down-Regulation of Proteins Involved in Peptidoglycan and Fatty Acid Biosynthesis. FEBS Open Bio 2019, 9, 2025–2040. [Google Scholar] [CrossRef] [PubMed]
  124. Neagu, R.; Popovici, V.; Ionescu, L.E.; Ordeanu, V.; Popescu, D.M.; Ozon, E.A.; Gîrd, C.E. Antibacterial and Antibiofilm Effects of Different Samples of Five Commercially Available Essential Oils. 2023, 12, 1191. [Google Scholar] [CrossRef]
  125. Ormai, E.; Bordás, B.; Kocsis, M.; Kerekes, E.; Biró, V.; Kocsis, B.; Szilágyi-Utczás, M.; Nagy, A.; Ollmann, T.; Horváth, G.; et al. Anti-Biofilm Activity of Tea Tree, Peppermint, Clove, Thyme Essential Oils and the Combination of the Most Effective Oils with Antibiotics against Bacteria Associated with Nosocomial Infections. Journal of Essential Oil Research 2025, 37, 469–486. [Google Scholar] [CrossRef]
  126. Elghali, F.; Ibrahim, I.; Guesmi, M.; Frikha, F.; Mnif, S. Unveiling the Impact of Selected Essential Oils on MRSA Strain ATCC 33591: Antibacterial Efficiency, Biofilm Disruption, and Staphyloxanthin Inhibition. Brazilian Journal of Microbiology 2024, 55. [Google Scholar] [CrossRef] [PubMed]
  127. Shahdadi, F.; Faryabi, M.; Khan, H.; Sardoei, A.S.; Fazeli-Nasab, B.; Goh, B.H.; Goh, K.W.; Tan, C.S. Mentha Longifolia Essential Oil and Pulegone in Edible Coatings of Alginate and Chitosan: Effects on Pathogenic Bacteria in Lactic Cheese. Molecules 2023, 28, 4554. [Google Scholar] [CrossRef] [PubMed]
  128. Zhao, W.; Yang, C.; Zhang, N.; Peng, Y.; Ma, Y.; Gu, K.; Liu, X.; Liu, X.; Liu, X.; Liu, Y.; et al. Menthone Exerts Its Antimicrobial Activity Against Methicillin Resistant Staphylococcus Aureus by Affecting Cell Membrane Properties and Lipid Profile. Drug Des. Devel. Ther. 2023, 17. [Google Scholar] [CrossRef]
  129. Farhanghi, A.; Aliakbarlu, J.; Tajik, H.; Mortazavi, N.; Manafi, L.; Jalilzadeh-Amin, G. Antibacterial Interactions of Pulegone and 1,8-cineole with Monolaurin Ornisin against Staphylococcus Aureus. Food Sci. Nutr. 2022, 10, 2659–2666. [Google Scholar] [CrossRef]
  130. Al-Ghamdi, A.; Elkholy, T.; Abuhelal, S.; Al-Abbadi, H.; Qahwaji, D.; Khalefah, N.; Sobhy, H.; Abu-Hilal, M. Antibacterial and Antifungal Activity of Jojoba Wax Liquid (Simmondsia Chinensis). Pharmacognosy Journal 2019, 11, 191–194. [Google Scholar] [CrossRef]
  131. Millot, M.; Girardot, M.; Dutreix, L.; Mambu, L.; Imbert, C. Antifungal and Anti-Biofilm Activities of Acetone Lichen Extracts against Candida Albicans. Molecules 2017, 22. [Google Scholar] [CrossRef]
  132. Nithyanand, P.; Beema Shafreen, R.M.; Muthamil, S.; Karutha Pandian, S. Usnic Acid Inhibits Biofilm Formation and Virulent Morphological Traits of Candida Albicans. Microbiol. Res. 2015, 179. [Google Scholar] [CrossRef]
  133. Varshan, G.S.A.; Namasivayam, S.K.R. A Critical Review on Sustainable Formulation of Anti-Quorum Sensing Compounds Using Nanotechnology Principles Against Candida Albicans. Bionanoscience 2025, 15, 161. [Google Scholar] [CrossRef]
  134. Tabassum, N.; Khan, F.; Jeong, G.-J.; Oh, D.K.; Kim, Y.-M. Controlling Oral Polymicrobial Biofilm Using Usnic Acid on the Surface of Titanium in the Artificial Saliva Media. Antibiotics 2025, 14, 115. [Google Scholar] [CrossRef]
  135. Abd El-Hack, M.E.; Kamal, M.; Altaie, H.A.A.; Youssef, I.M.; Algarni, E.H.; Almohmadi, N.H.; Abukhalil, M.H.; Khafaga, A.F.; Alqhtani, A.H.; Swelum, A.A. Peppermint Essential Oil and Its Nano-Emulsion: Potential against Aflatoxigenic Fungus Aspergillus Flavus in Food and Feed. Toxicon 2023, 234, 107309. [Google Scholar] [CrossRef] [PubMed]
  136. Saharkhiz, M.J.; Motamedi, M.; Zomorodian, K.; Pakshir, K.; Miri, R.; Hemyari, K. Chemical Composition, Antifungal and Antibiofilm Activities of the Essential Oil of Mentha Piperita L. ISRN Pharm. 2012, 2012, 1–6. [Google Scholar] [CrossRef] [PubMed]
  137. Sopyan, I.; Siagian, V.H.M.; Cung, J.; Wulandari, D. An Emerging of Essential Oils with Antifungal Activities as Anti-Dandruff in Formulation. Indonesian Journal of Pharmacy 2025. [Google Scholar] [CrossRef]
  138. Doğanay, D.; Mertoğlu, E.; Özkanca, C.; Canbay, Y.; Elmastaş, M. Determination of the Antimicrobial and Antioxidant Capacity of Mentha Dumetorum Essential Oil. Bull. Chem. Soc. Ethiop. 2026, 40, 1091–1103. [Google Scholar] [CrossRef]
  139. Desam, N.R.; Al-Rajab, A.J.; Sharma, M.; Mylabathula, M.M.; Gowkanapalli, R.R.; Albratty, M. Chemical Constituents, in Vitro Antibacterial and Antifungal Activity of Mentha × Piperita L. (Peppermint) Essential Oils. J. King Saud Univ. Sci. 2019, 31, 528–533. [Google Scholar] [CrossRef]
  140. Rajkowska, K.; Otlewska, A.; Kunicka-Styczyńska, A.; Krajewska, A. Candida Albicans Impairments Induced by Peppermint and Clove Oils at Sub-Inhibitory Concentrations. Int. J. Mol. Sci. 2017, 18. [Google Scholar] [CrossRef]
  141. Ungurianu, A.; Şeremet, O.; Gagniuc, E.; Olaru, O.T.; Guţu, C.; Grǎdinaru, D.; Ionescu-Tȋrgovişte, C.; Marginǎ, D.; Dǎnciulescu-Miulescu, R. Preclinical and Clinical Results Regarding the Effects of a Plant-Based Antidiabetic Formulation versus Well Established Antidiabetic Molecules. Pharmacol. Res. 2019, 150, 104522. [Google Scholar] [CrossRef]
  142. Nicholson, S.K.; Tucker, G.A.; Brameld, J.M. Physiological Concentrations of Dietary Polyphenols Regulate Vascular Endothelial Cell Expression of Genes Important in Cardiovascular Health. British Journal of Nutrition 2010, 103, 1398–1403. [Google Scholar] [CrossRef]
  143. MARGINĂ, D.; OLARU, O.T.; ILIE, M.; GRĂDINARU, D.; GUȚU, C.; VOICU, S.; DINISCHIOTU, A.; SPANDIDOS, D.A.; TSATSAKIS, A.M. Assessment of the Potential Health Benefits of Certain Total Extracts from Vitis Vinifera, Aesculus Hyppocastanum and Curcuma Longa. Exp. Ther. Med. 2015, 10, 1681–1688. [Google Scholar] [CrossRef]
  144. Caballero-Gallardo, K.; Quintero-Rincón, P.; Stashenko, E.E.; Olivero-Verbel, J. Photoprotective Agents Obtained from Aromatic Plants Grown in Colombia: Total Phenolic Content, Antioxidant Activity, and Assessment of Cytotoxic Potential in Cancer Cell Lines of Cymbopogon Flexuosus L. and Tagetes Lucida Cav. Essential Oils. Plants 2022, 11, 1693. [Google Scholar] [CrossRef]
  145. El Aanachi, S.; Gali, L.; Nacer, S.N.; Bensouici, C.; Dari, K.; Aassila, H. Phenolic Contents and in Vitro Investigation of the Antioxidant, Enzyme Inhibitory, Photoprotective, and Antimicrobial Effects of the Organic Extracts of Pelargonium Graveolens Growing in Morocco. Biocatal. Agric. Biotechnol. 2020, 29, 101819. [Google Scholar] [CrossRef]
  146. da Silva, A.C.P.; Paiva, J.P.; Diniz, R.R.; dos Anjos, V.M.; Silva, A.B.S.M.; Pinto, A.V.; dos Santos, E.P.; Leitão, A.C.; Cabral, L.M.; Rodrigues, C.R.; et al. Photoprotection Assessment of Olive (Olea Europaea L.) Leaves Extract Standardized to Oleuropein: In Vitro and in Silico Approach for Improved Sunscreens. J. Photochem. Photobiol. B 2019, 193, 162–171. [Google Scholar] [CrossRef]
  147. De Castro, T.L.A.; Pinto, G.A. do C.; Cardoso, C.A.L. A Systematic Review of the Photoprotective Potential of Native Edible Plants from Mato Grosso Do Sul, Brazil. Orbital: The Electronic Journal of Chemistry 2022, 14, 182–189. [Google Scholar] [CrossRef]
  148. Kada, Z.O.; Benhelima, A.; Daoidi, S.; Sahki, R.; Ghali, N. Antibacterial, Antibiofilm and Sun Protection Factor of Artemisia Judaica Essential Oil from Pharmacopoeia of Tassili N’ajjer. Journal of Essential Oil Bearing Plants 2023, 26, 522–533. [Google Scholar] [CrossRef]
  149. Pegorin, G.S.; Marques, M.O.M.; Mayer, C.R.M.; Santos, L. Development of a Phytocosmetic Enriched with Pequi (Caryocar Brasiliense Cambess) Oil. Brazilian Archives of Biology and Technology 2020, 63. [Google Scholar] [CrossRef]
  150. Ferrari, M.; da Rocha-Filho, P.A. Multiple Emulsions Containing Amazon Oil:Açaí Oil (Euterpe Oleracea). Revista Brasileira de Farmacognosia 2011, 21. [Google Scholar] [CrossRef]
  151. Adewinogo, S.O.; Sharma, R.; Africa, C.W.J.; Marnewick, J.L.; Hussein, A.A. Chemical Composition and Cosmeceutical Potential of the Essential Oil of Oncosiphon Suffruticosum (L.) Källersjö. Plants 2021, 10, 1315. [Google Scholar] [CrossRef]
  152. Reis Mansur, M.C.P.P.; Leitão, S.G.; Cerqueira-Coutinho, C.; Vermelho, A.B.; Silva, R.S.; Presgrave, O.A.F.; Leitão, Á.A.C.; Leitão, G.G.; Ricci-Júnior, E.; Santos, E.P. In Vitro and in Vivo Evaluation of Efficacy and Safety of Photoprotective Formulations Containing Antioxidant Extracts. Revista Brasileira de Farmacognosia 2016, 26, 251–258. [Google Scholar] [CrossRef]
  153. Nedea (Ilie), M.I.; Bădiceanu, C.D.; Gheorghe-Barbu, I.; Marinaș, I.C.; Pericleanu, R.; Dragomir, R.-I.; Dumbravă, A. Ștefania; Dascălu, A.M.; Șerban, D.; Tudor, C.; et al. Antifungal and Antioxidant Activity of Thiourea Derivatives Against Nosocomial Candida Auris Strains Isolated in Romania. Molecules 2025, 30, 1675. [Google Scholar] [CrossRef]
Figure 1. (A,B) Optical density (OD) values of different dilutions of PJO (A) and UBPJO (B); (C,D) Antioxidant capacity of various dilutions of PJO (C) and UBPJO (D) expressed as % decrease of optical density – ΔOD (%); DOD = ΔOD.
Figure 1. (A,B) Optical density (OD) values of different dilutions of PJO (A) and UBPJO (B); (C,D) Antioxidant capacity of various dilutions of PJO (C) and UBPJO (D) expressed as % decrease of optical density – ΔOD (%); DOD = ΔOD.
Preprints 204152 g001
Figure 2. Antioxidant effect through the ABTS method, expressed as % decrease of optical density – ΔOD (%) at different dilutions of PJO (A) and UBPJO (B); DOD = ΔOD.
Figure 2. Antioxidant effect through the ABTS method, expressed as % decrease of optical density – ΔOD (%) at different dilutions of PJO (A) and UBPJO (B); DOD = ΔOD.
Preprints 204152 g002
Figure 3. Variation of SPF values, in the wavelength range of 290-320 nm at 5 nm intervals, for PJO and UBPJO; PJO – Jojoba oil with 5% Peppermint Essential Oil; UBPJO – U. barbata oil extract. Dilutions 1-6 = 1:10; 1:5; 1:4; 1:2; 1:1; stock solution.
Figure 3. Variation of SPF values, in the wavelength range of 290-320 nm at 5 nm intervals, for PJO and UBPJO; PJO – Jojoba oil with 5% Peppermint Essential Oil; UBPJO – U. barbata oil extract. Dilutions 1-6 = 1:10; 1:5; 1:4; 1:2; 1:1; stock solution.
Preprints 204152 g003
Figure 4. (A) Antimicrobial activity: MIC values of UBPJO, PJO, and Tween 80 against C. albicans, E coli, and S. aureus. (B,C) Antibiofilm activity: Adherence capacity inhibition percentage (ACIP %) for PJO (B) and UBPJO (C) against tested microorganisms.
Figure 4. (A) Antimicrobial activity: MIC values of UBPJO, PJO, and Tween 80 against C. albicans, E coli, and S. aureus. (B,C) Antibiofilm activity: Adherence capacity inhibition percentage (ACIP %) for PJO (B) and UBPJO (C) against tested microorganisms.
Preprints 204152 g004aPreprints 204152 g004b
Table 1. Contributions and synergistic roles of all four constituents of U. barbata oil extract, and the main phytoconstituents responsible for UBPJO pharmacological properties.
Table 1. Contributions and synergistic roles of all four constituents of U. barbata oil extract, and the main phytoconstituents responsible for UBPJO pharmacological properties.
Ingredient Primary Contribution Synergistic Role References
Jojoba Oil Carrier, emollient, skin barrier support Stable lipid matrix that protects and delivers other actives [42]
Peppermint Oil (5%) Antimicrobial, cooling, antioxidant Adds volatile compounds; enhances penetration via cooling/vasodilatory effect [43,44,45,46,47,48,49]
Vitamin E (10%) Lipid-soluble antioxidant, photoprotection Regenerates other antioxidants; protects unsaturated components from oxidation [50,51]
U. barbataextract Phenolic-rich, antioxidant, antimicrobial, and potential UV-filter Strongly boosts TPC; extends oxidative stability; adds lichen-specific bioactive metabolites [5,52,53,54,55,56,57]
Main constituents Samples
PJO [41] UBPJO [41]
TPC (µg GAE/g) 247.56 297.27
Volatile constituents (%) PEO [58] PJO [41] UBPJO [41]
L-Limonene 2.08 9.93 7.11
(+/-)-Linalool 0.06 0.11 -
L-menthone - 3.94 2.97
(-)-isomenthone / cis-p-Menthan-3-one 26.52 18.34 19.50
Methyl chavicol/ estragole - 8.99 7.81
trans-Carveol - 1.10 0.80
Neoisomenthol 55.09 - -
Eucalyptol 5.04 - -
(+)-Pulegone - 29.93 41.66
Carvone - 0.64 1.38
8-Hydroxy-p-menthan-3-one - 1.34 1.62
Limonene-1,2-diol/ Limonene glycol - 1.33 0.52
Methyleugenol - 1.63 0.95
trans-Caryophyllene 1.61 0.81 0.51
TPC – Total phenolic content; PJO—Jojoba oil with 5% Peppermint Essential Oil and 10% Vitamin E; UBPJO—U. barbata oil extract.
Table 2. Minimum inhibitory concentration (MIC) values.
Table 2. Minimum inhibitory concentration (MIC) values.
Microbial strain MIC (mg/mL)
Positive control Oil samples
T80 PJO UBPJO
Staphylococcus aureus ATCC 25923 50 ± 0.00 a 37.50 ± 0.00 a 18.75 ± 6.25 a
Escherichia coli ATCC25922 37.50 ± 12.50 50 ± 0.00 50 ± 0.00
Candida albicans ATCC10231 50 ± 0.00 b 37.50 ±12.50 c 9.62 ± 2.87 b,c
T80 = Tween 80 20% in ethanol; PJO = Jojoba oil enriched with 5% Peppermint oil and 10% vitamin E; UBPJO = U. Barbata extract in PJO. The differences between values noted with the same superscript letter in the same row are statistically significant.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated